Analysis of data from TCGA genomics program, the GEPIA web server and the Oncomine database revealed that higher levels of ANGPTL2 expression were correlated with progressive disease and lymph node metastasis. The gene discussed is ANGPTL2; the disease is metastatic malignant neoplasm in the lymph nodes.